Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

kelly smith

Cara Priest

OPEN Health Appoints Cara Priest as Chief People Officer to Strengthen Culture, Capability and Organisational Performance

OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and scientific excellence.

OPEN Health

- PMLiVE

Sandoz appoints Armin Metzger as President of new global unit

Metzger was most recently Executive VP, Chief Technical Operations Officer at Ferring Pharmaceuticals

- PMLiVE

WHO releases new target product profiles for urgently needed antibiotics

The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, pneumonia and meningitis

- PMLiVE

BioDuro appoints Andrew Thomas and Stevan Djuric as Scientific Advisors

Thomas and Djuric formerly held senior roles at Roche and AbbVie, respectively

- PMLiVE

AstraZeneca’s Imfinzi approved in EU for early gastric and gastro-oesophageal cancers

This is the first and only perioperative immunotherapy approved to treat early gastric cancers

- PMLiVE

Odyssey Therapeutics appoints H Martin Seidel to Scientific Advisory Board

Seidel was previously Head of the Genomics Institute of the Novartis Research Foundation

- PMLiVE

MHRA approves Leqselvi for severe alopecia areata

Around 30% of patients saw 80% more scalp hair after 24 weeks of treatment

- PMLiVE

Athlone Laboratories hosts ministerial visit to discuss the future of critical medicines in Ireland

Minister Peter Burke, and representatives from IDA Ireland met with the company’s leadership team

- PMLiVE

Smarter Learning and Better Outcomes: How AI Can Provide an Advantage in Medical Education

See how AI-powered patient avatars allow physicians to test complex diagnoses and treatment plans in a simulated environment.

Impetus Digital

- PMLiVE

Bristol Myers Squibb’s Sotyktu approved by US FDA for psoriatic arthritis

Sotyktu is the first TYK2 inhibitor approved for active psoriatic arthritis

- PMLiVE

Inizio Ignite announces key leadership appointments

The appointments have been announced amid team mergers

- PMLiVE

Commit Biologics appoints Thomas Montgomery Andresen as CEO

Andresen was CEO of T-Cypher Bio, an Oxford, UK-based immunotherapy company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links